Farsoon Technologies partners with Emlogic to expand industrial polymer and metal AM in Australia and New Zealand

Farsoon Technologies, the Chinese industrial additive manufacturing systems manufacturer, has entered a strategic distribution and service partnership with Emlogic, a Melbourne-based engineering solutions provider. The agreement, announced in early May 2026, designates Emlogic as Farsoon's exclusive partner for Australia and New Zealand, tasked with sales, technical support, and application development for Farsoon's full portfolio of polymer laser sintering (SLS) and metal laser powder bed fusion (LPBF) systems. The partnership aims to deepen Farsoon's penetration into the region's industrial manufacturing sectors, leveraging Emlogic's established local engineering network and customer base.

This move is a textbook execution of the Chinese localization and export arc, where a domestic leader, having scaled through a deep home-market supply chain, now systematically targets international industrial corridors. Farsoon, a significant player in the global polymer SLS and metal PBF-LB segments, is not merely exporting hardware but a complete ecosystem, including materials and qualified process parameters. The partnership targets the economically important but often media-invisible industrial tooling and prototyping vertical, where local technical support and application know-how are critical purchase drivers. It represents a calculated expansion into a fragmented but growing regional market, competing directly with established Western OEMs and other Asian manufacturers for mid-tier industrial customers who prioritize total cost of ownership over brand legacy.

The practical outcome hinges on Emlogic's ability to translate Farsoon's technical specifications into validated, production-ready local use cases. Success will be measured not by unit sales alone, but by the number of qualified, recurring part applications developed for Australian and New Zealand manufacturers in sectors like aerospace subcontracting, medical device prototyping, and specialized tooling. For buyers in the region, this partnership offers a potentially more cost-competitive and responsive alternative to the traditional European and American OEMs, provided the local support infrastructure matures as promised.